Company
Silence Therapeutics
Precision Engineered Medicines to Silence Diseases
Also known as Silence Therapeutics plc
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- London, United Kingdom
- Legal name
- Silence Therapeutics plc
- silence-therapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Record updated 28 September 2026
About
At Silence, we aim to transform peoples’ lives around the world by silencing diseases through our precision engineered medicines and driving positive change for the communities around us. As pioneers in the design and development of siRNAs (short interfering RNAs), we are advancing a new generation of medicines to potentially address the needs of patients who have limited or inadequate treatment options.
Funding snapshot
- Total raised
- $45.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $45.5M2021-02-04
Funding rounds
- Round, 2021
- $45.5M2021-02-04, SEC form D sold, 12 investors
- Round, 2010
- 2010-01-05